Epitomee Medical logo

Epitomee Medical

We develop paradigm-shifting ingestible therapeutic devices that deploy targeted therapies along the GI tract

34 employees · est. 2005 · Caesarea, Israel

VS
Interface Biologics logo

Interface Biologics

6 employees · est. 2001 · Toronto, Canada

Interface Biologics is the older company (2005 vs 2001); Epitomee Medical is the larger of the two.

Side-by-Side Comparison

Epitomee Medical Interface Biologics
Founded
2005 2001 older
Headquarters
Caesarea, Israel Toronto, Canada
Employees
34 larger 6
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
Series A Series B
Total Funding
$8.00M $32.00M
Funding Rounds
1 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Drug Delivery, Oral Delivery, Therapeutic Devices, Ingestible Devices, Weight Management, GI Tract, Biologics Delivery Biomedical Polymer Technology, Anti-thrombogenic Additives, Thrombosis Reduction, Drug Delivery Devices
Website
epitomeemedical.com interfacebiologics.com
Epitomee Medical logo

About Epitomee Medical

Epitomee Medical is a biotechnology and healthcare startup based in Israel, specializing in the development of ingestible therapeutic devices. Established in 2005, the company's mission is to revolutionize the treatment of chronic diseases using self-managed, safe, and effective solutions. Their fla...

Interface Biologics logo

About Interface Biologics

Interface Biologics is a Canadian startup founded in 2001 that focuses on developing transformative biomedical polymer technology to enhance the safety and effectiveness of medical devices. Its primary technology areas include anti-thrombogenic additives that reduce thrombosis in blood-contacting me...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Epitomee Medical and Interface Biologics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Epitomee Medical and Interface Biologics — by email.

Frequently Asked Questions

Epitomee Medical — We develop paradigm-shifting ingestible therapeutic devices that deploy targeted therapies along the GI tract. Interface Biologics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Epitomee Medical has raised $8.00M while Interface Biologics has raised $32.00M.
Epitomee Medical and Interface Biologics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Epitomee Medical with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy